Colcrys and Taztia xt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colcrys (colchicine) and Taztia xt (diltiazem hydrochloride). Common drug interactions include hyperparathyroidism secondary among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Colcrys and Taztia xt. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.

What is Taztia xt?

Taztia xt has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 621 Taztia xt users. Check the latest studies of Taztia xt.



On Jul, 14, 2026

13 people who take Colcrys and Taztia xt together, and have interactions are studied.

Colcrys and Taztia xt drug interactions.

What are the common drug interactions of Colcrys and Taztia Xt, by gender? *:

female:

  1. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Chronic kidney disease
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)

male:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Renal injury (kidney injury)
  6. Death
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

What are the common drug interactions of Colcrys and Taztia Xt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Renal injury (kidney injury)
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal impairment (severely reduced kidney function)

60+:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Renal failure (kidney dysfunction)
  5. Renal impairment (severely reduced kidney function)
  6. Renal injury (kidney injury)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 92.31%
  2. Pain: 11 people, 84.62%
  3. High Blood Cholesterol: 6 people, 46.15%
  4. Irritable Bowel Syndrome: 5 people, 38.46%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 38.46%
  6. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 5 people, 38.46%
  7. Diabetes: 5 people, 38.46%
  8. Infection: 5 people, 38.46%
  9. Depression: 5 people, 38.46%
  10. Headache (pain in head): 5 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Colcrys and Taztia xt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Colcrys and Taztia xt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Taztia xt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colcrys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taztia xt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on colchicine and diltiazem hydrochloride (the active ingredients of Colcrys and Taztia xt, respectively), and Colcrys and Taztia xt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: